Vijaya Diagnostic Centre Limited (NSE:VIJAYA)

Market Cap	89.55B -17.3%
Revenue (ttm)	7.68B +15.8%
Net Income	1.59B +12.2%
EPS	15.48 +12.1%
Shares Out	102.90M
PE Ratio	56.21
Forward PE	44.57
Dividend	2.00 (0.23%)
Ex-Dividend Date	Aug 29, 2025

Volume	168,462
Average Volume	106,325
Open	865.00
Previous Close	870.30
Day's Range	848.00 - 869.90
52-Week Range	813.15 - 1,180.00
Beta	-0.17
RSI	28.92
Earnings Date	May 8, 2026

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyder...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 2,218
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIJAYA

Financial Performance

In fiscal year 2025, Vijaya Diagnostic Centre's revenue was 6.81 billion, an increase of 24.39% compared to the previous year's 5.48 billion. Earnings were 1.43 billion, an increase of 20.41%.